Smith, Perry E – Trademark Portfolio
Entity Type: 01
Smith, Perry E holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 7 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include FEMINOPATHY and HOMEOPATHYWORKS. The owner is based in OCEAN RIDGE, FL.
5505 N. Ocean Blvd. Sussex 15-104
5505 North Ocean Blv. 15-104
OCEAN RIDGE, FL 33435
Showing of trademarks Trademarks
Trademark Classifications
Smith, Perry E's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Smith, Perry E have?
Smith, Perry E has 11 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending, 8 abandoned.
What trademark classes does Smith, Perry E file in?
Smith, Perry E files trademarks across 3 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Smith, Perry E's most well-known trademarks?
Smith, Perry E's registered trademark portfolio includes well-known marks such as FEMINOPATHY and HOMEOPATHYWORKS. These are among 2 currently registered trademarks in the portfolio.
What is Smith, Perry E's trademark registration success rate?
Smith, Perry E has a 20% trademark registration rate, with 2 out of 10 resolved applications resulting in successful registration. Currently, 1 application is pending review.